This increase in IL-27 was associated with improvements in blood lipid profiles and a reduction in insulin resistance, suggesting a possible role of IL-27 in mediating the anti-obesity effects of gut microbiota-modulating interventions, but further mechanistic investigations are needed to clarify the interactions between IL-27 and microbiota. The gene discussed is IL27; the disease is obesity disorder.